Psorent® Psoriasis Topical Solution is clinically proven and specially formulated to help relieve the symptoms of mild to moderate psoriasis such as:
This steroid-free formulation helps to prevent recurrence when used regularly. Psorent® Psoriasis Topical Solution applies easily with a convenient, no-mess applicator and dries quickly.
Recommended usage: 1 or 2 times daily or as directed by a doctor.
Size: 3.2 fl oz bottle
Read warnings before use. Use only as directed
Apply to scalp and/or skin one to two times daily or as directed by a doctor. If use on scalp is desired, test in a small, discrete spot first to make sure solution will not discolor hair.
When using this product:
Stop and ask a doctor if rash or irritation develops, or if condition worsens or does not improve after regular use of this product as directed. Keep out of reach of children. If swallowed, get medical help or contact a poison control center right away. This product can expose you to coal tar, a chemical known to the State of California to cause cancer. For more information, go to www.p65Warnings.ca.gov/product.
Active Ingredient: Coal Tar 2.3% (from Coal Tar Topical Solution, USP 15%) Psoriasis Treatment
Inactive Ingredients: Alcohol Denat., Cyclohexasiloxane, Cyclopentasiloxane, Dioctyldodecyl Dodecanedioate, Oleth-2, Parfum (Fragrance), Polysorbate 80, Propylene Glycol, Triethyl Citrate.
Warning: This product can expose you to coal tar, a chemical known to the State of California to cause cancer. For more information, go to www.p65Warnings.ca.gov/product.
Store upright at 15º-30ºC (59º-86ºF). Keep away from extreme heat, cold, and direct sunlight. Do not bring on an airplane, as leakage may occur in luggage. If the applicator becomes dirty or clogged, gently wipe with an alcohol pad. May stain your skin, hair, nails, clothing, and other household surfaces that come in contact with the medication. As with all topical medications, wash your hands after each application.
Improvement noted after 8 weeks of twice daily use. M. B. Alora-Palli, et al., Am J Clin Dermatol 2010; 11(4):275-283.